Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thymoglobuline in Non-myeloablative Allogeneic SCT
NCT00130754Phase 3Completed
- Sponsor
- Hadassah Medical Organization
- Start
- Feb 2005
- Modality
- Recombinant Proteins and Enzymes, Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of antithymocyte globulin rabbit in graft-versus-host disease (GVHD), sponsored by Hadassah Medical Organization. Started Feb 2005; status: completed.
02
Drugs
antithymocyte globulin rabbit
03
Conditions
graft-versus-host disease (GVHD)
Beyond the preview
Go deeper on NCT00130754.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00130754.